Florida Cancer Specialists & Research Institute Announces Senior Leadership Promotions & Appointments

Coverage from the 64th Annual American Society of Hematology Meeting and Exposition, December 10-13, 2022, New Orleans, Louisiana.

On this episode of Managed Care Cast, Consuelo Wilkins, MD, MSCI, discusses efforts to improve racial and ethnic disparities in US chronic disease rates.

In abstracts presented at the 64th American Society of Hematology Annual Meeting and Exposition, the investigational BTK inhibitor pirtobrutinib showed promising efficacy and safety in several types of B-cell lymphoma.

On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).

An analysis presented during the 64th American Society of Hematology Annual Meeting and Exposition showed that patients with multiple myeloma were able to experience improved responses to the proteasome inhibitor ixazomib after switching from bortezomib.

A new study highlighted that patients with diabetes enrolled in Medicare Advantage (MA) had better outcomes compared with patients in traditional fee-for-service (FFS) Medicare.